Mechanism-driven multitarget therapeutics for diabetic peripheral neuropathy.

Area of Science:

• Neurology
• Endocrinology
• Pharmacology

Background:

• Diabetic Peripheral Neuropathy (DPN) is a common diabetes complication affecting nerve function and quality of life.
• Current DPN treatments are limited by complex pathogenesis, necessitating novel therapeutic strategies.
• Understanding DPN's intricate mechanisms is crucial for developing effective interventions.

Purpose of the Study:

• To systematically review the complex pathogenic mechanisms underlying Diabetic Peripheral Neuropathy.
• To discuss recent advancements in multi-target drug development for DPN.
• To provide insights into potential therapeutic strategies for DPN.

Main Methods:

• Literature review of DPN pathogenesis.
• Analysis of multi-target drug classes including antioxidants, anti-inflammatories, nerve regeneration promoters, and microcirculation modulators.
• Evaluation of the clinical potential of emerging DPN therapies.

Main Results:

• DPN pathogenesis involves oxidative stress, mitochondrial dysfunction, neuroinflammation, and neurotrophic factor deficiency.
• Several classes of multi-target drugs show promise for DPN treatment.
• Antioxidants, anti-inflammatory agents, nerve regeneration promoters, and microcirculation modulators are key areas of research.

Conclusions:

• Effective DPN management requires addressing its multifaceted pathogenic mechanisms.
• Multi-target drug development offers a promising avenue for novel DPN therapies.
• Further research into these strategies could significantly improve patient outcomes.